Loxapine Catalog No.:M9964-10 Pefloxacin has not been approved

Pefloxacin has not been approved for use in the United States

InChi: InChI=1S/C10H21N3O

AT-101 is a small molecule inhibitor of Bcl-2/Bcl-xL/Mcl-1 that potently induces apoptosis in various cancer cell lines

and inhibits arachidonic acid conversion into the thromboxane-2 and prostaglandin-2 families

11aS)-11a-ethyl-1-ethynyl-1-hydroxy-10-methylidene-1H

Loxapine Catalog No.:M9964-10 Pefloxacin has not been approvedLoxapine is a typical antipsychotic medication, used primarily in the treatment of schizophrenia. The drug is a member of the dibenzoxazepine class and structurally related to clozapine (which belongs to the chemically akin class of dibenzodiazepines). Several researchers have argued that loxapine may behave as an atypical antipsychotic. Loxapine may be metabolized by N demethylation to amoxapine, a tetracyclic antidepressant. Product information CAS